BIOMAT Database Logo BIOMAT Database Logo

Prognostic significance of N-myc amplification in neuroblastoma. 1990

G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone

UI MeSH Term Description Entries
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience.
July 1991, Cancer genetics and cytogenetics,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Neuroblastoma and the clinical significance of N-myc oncogene amplification.
January 1991, Surgery, gynecology & obstetrics,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
N-myc oncogene amplification and prognostic factors of neuroblastoma in children.
October 1987, Journal of pediatric surgery,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Amplification of N-myc as a prognostic marker for patients with neuroblastoma.
February 1993, Seminars in cancer biology,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
November 1993, Cancer,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Surgical aspects of N-myc oncogene amplification of neuroblastoma.
July 1988, Surgery,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification.
January 1991, Progress in clinical and biological research,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Characterization of N-myc amplification units in human neuroblastoma cells.
February 1988, Molecular and cellular biology,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Amplification and expression of the N-myc gene in neuroblastoma.
March 1987, European journal of pediatrics,
G P Tonini, and P Cornaglia-Ferraris, and V Fontana, and P Strigini, and R Sansone
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
December 1990, Oncogene,
Copied contents to your clipboard!